Begrænset evidens for monitorering og behandling af fosfatmangel hos kritisk syge patienter

Christine Federspiel, Theis S Itenov, Katrin Thormar, Morten H Bestle

1 Citationer (Scopus)

Abstract

Hypophosphataemia is a potentially hazardous metabolic disturbance which is common in critically ill patients. The condition is reported to be associated with severe complications and increased mortality. It is unknown, whether hypophosphataemia has a causal effect or reflects the severity of illness. There are no randomized clinical trials to support treatment of hypophosphataemia with intravenous phosphate substitution, which has resulted in large variations in monitoring and treatment of hypophosphataemia in the intensive care unit.

Bidragets oversatte titelLimited evidence for monitoring and treatment of hypophosphataemia in critically ill patients
OriginalsprogDansk
ArtikelnummerV07150610
TidsskriftUgeskrift for Laeger
Vol/bind177
Udgave nummer50
Sider (fra-til)V07150610
ISSN0041-5782
StatusUdgivet - 7 dec. 2015

Fingeraftryk

Dyk ned i forskningsemnerne om 'Begrænset evidens for monitorering og behandling af fosfatmangel hos kritisk syge patienter'. Sammen danner de et unikt fingeraftryk.

Citationsformater